No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)
暂无分享,去创建一个
J. Maciejewski | H. Carraway | A. Advani | M. Sekeres | M. Kalaycio | A. Nazha | S. Mukherjee | A. Gerds | N. Majhail | L. Iglesias